Literature DB >> 401833

Comparative serological and cutaneous reactivity of candidal cytoplasmic proteins and mannan separated by affinity for concanavalin A.

J H Ellsworth, E Reiss, R L Bradley, H Chmel, D Armstrong.   

Abstract

Yeast-form Candida albicans cells were disrupted for 1.5 min in a Braun homogenizer and centrifuged at 100,000 X g. The supernatant was concentrated by ammonium sulfate precipitation and then dialyzed. The resulting material (650 mg), containing 81.2% protein and 11.5% carbohydrate, was subjected to affinity chromatography on concanavalin A (Con A) linked to agarose. A protein fraction was eluted from the column with buffer, and a fraction containing mannan was eluted with 0.2 M alpha-methyl mannoside. The candidal soluble proteins had 19 components which were resolvable by polyacrylamide gel electrophoresis. The material with affinity for Con A contained mannan and 17% complexed protein. Antigenic differences between the soluble proteins and the mannan-protein complex were shown by lines of intersection in immunodiffusion. The soluble proteins devoid of mannan reacted in immunoelectrophoresis with sera from infected rabbits and patients with chronic candidiasis. These same sera also reacted with a mannan-protein complex eluted from the Con A column with alpha-methyl mannoside. The comparative ability of candidal proteins and cell wall-derived mannan to elicit skin test reactions in guinea pigs sensitized by infection or with formaldehyde-killed yeast was studied. Candidal proteins at a 10-mug dose elicited positive reactions at 6 and 21 days after sensitization. The reactions persisted for 48 h and showed minimal tendency to an arthus response, which was marked when mannan-containing antigens were used. The antigenicity of cell wall-derived mannans and candidal soluble proteins devoid of mannan was compared in immunodiffusion tests of sera from 39 patients with neoplastic disease. Of these patients with documented candidiasis, 13 of 20 reacted to one or more mannan antigens, and 3 of 20 reacted to candidal soluble proteins. In contrast, of those patients who were uninfected or had superficial Candida spp. infections, 5 of 19 reacted to candidal soluble proteins, and 16 of 19 reacted to one or more mannan antigens.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 401833      PMCID: PMC274538          DOI: 10.1128/jcm.5.1.91-99.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  POLYSACCHARIDE ANTIGENS OF CANDIDA CELL WALL.

Authors:  D F SUMMERS; A P GROLLMAN; H F HASENCLEVER
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  Current concepts of diagnostic serology and skin hypersensitivity in the mycoses.

Authors:  S B SALVIN
Journal:  Am J Med       Date:  1959-07       Impact factor: 4.965

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 4.  Serological diagnosis of candidal infections.

Authors:  C L Taschdjian; M S Seelig; P J Kozinn
Journal:  CRC Crit Rev Clin Lab Sci       Date:  1973-07

5.  Affinity chromatography of hepatitis B antigen on concanavalin A linked to sepharose.

Authors:  A R Neurath; A M Prince; A Lippin
Journal:  J Gen Virol       Date:  1973-06       Impact factor: 3.891

6.  [Immunoelectrophoretic study of the nature and the order of appearance of precipitating antibodies of rabbit serum as a function of their mode of immunization against Candica albicans].

Authors:  J Biguet; P Tran Van Ky; S Andrieu; R Degaey
Journal:  Sabouraudia       Date:  1965-10

7.  Quantitative immunoelectrophoretic methods as tools for a polyvalent approach to standardization in the immunochemistry of Candida albicans.

Authors:  N H Axelsen
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

8.  Comparison of a newly developed latex agglutination test and an immunodiffusion test in the diagnosis of systemic candidiasis.

Authors:  D Stickle; L Kaufman; S O Blumer; D W McLaughlin
Journal:  Appl Microbiol       Date:  1972-03

9.  Serological and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls.

Authors:  E Reiss; S H Stone; H F Hasenclever
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

10.  Purification and properties of a glycoprotein acid phosphatase from Candida albicans.

Authors:  F C Odds; J C Hierholzer
Journal:  J Bacteriol       Date:  1973-04       Impact factor: 3.490

View more
  20 in total

1.  Detection of the 43,000-molecular-weight glycoprotein in sera of patients with paracoccidioidomycosis.

Authors:  M J Mendes-Giannini; J P Bueno; M A Shikanai-Yasuda; A W Ferreira; A Masuda
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

2.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Identification of C3d receptors on Candida albicans.

Authors:  R A Calderone; L Linehan; E Wadsworth; A L Sandberg
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

4.  Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans.

Authors:  J P Burnie; R C Matthews; A Fox; S Tabaqchali
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

5.  Increased specificity of antibody detection in surgical patients with invasive candidiasis with cytoplasmic antigens depleted of mannan residues.

Authors:  A J van Deventer; H J van Vliet; L Voogd; W C Hop; W H Goessens
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

6.  Diagnostic value of anti-Candida enolase antibodies.

Authors:  A J van Deventer; H J van Vliet; W C Hop; W H Goessens
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

7.  Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis.

Authors:  W M Scheld; R A Calderone; J P Brodeur; M A Sande
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

8.  Evaluation of enzyme immunoassay for Candida cytoplasmic antigens in neutropenic cancer patients.

Authors:  M Morhart; R Rennie; B Ziola; E Bow; T J Louie
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge.

Authors:  J E Domer; S A Moser
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

10.  Usefulness of serial antibody determinations in diagnosis of candidiasis as measured by discontinuous counterimmunoelectrophoresis using HS antigen.

Authors:  R Marier; V T Andriole
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.